EURACTIV PR

An easy way of publishing your relevant EU press releases.

Medicines for Europe

Press Releases of this organisation

TITLEsort descending ORGANISATION DATE TOPIC
European patients need improved access to biosimilar medicines Medicines for Europe Thu, 04/22/2021 Health & Consumers
Europe’s life science industry urges the UK and EU27 to safeguard patients’ access to medicines with a clear transition period and a future cooperation agreement after Brexit Medicines for Europe Tue, 11/28/2017 Health & Consumers, UK in Europe
Failure to launch: white paper explores the role of inappropriate use of IP in blocking access to generic and biosimilar medicines Medicines for Europe Thu, 11/05/2020 Health & Consumers
Fulfilling the Biosimilar Promise: Report Highlights Key Principles in Support of a Sustainable Market Medicines for Europe Mon, 09/19/2016 Health & Consumers
Future of pharmaceutical policy rests on secure supply of essential medicines Medicines for Europe Wed, 05/03/2023 Health & Consumers
Generic & biosimilar medicines pivotal for safe, effective and affordable access to medicines in Europe Medicines for Europe Thu, 11/28/2019 Health & Consumers
Generic medicine pricing reforms needed in Slovakia to ensure supply for patients Medicines for Europe Fri, 06/23/2023 Health & Consumers
Generic medicines: 70% of dispensed medicines and critical to healthcare Medicines for Europe Wed, 04/10/2024 Health & Consumers
Giving medicines a new life: EU should foster patients’ access to Value Added Medicines Medicines for Europe Wed, 11/30/2022 Health & Consumers
Harmonised bioequivalence guideline paves the way for global generic medicine development and access to medicines Medicines for Europe Wed, 04/26/2023 Health & Consumers
Health at a Glance Report highlights public value of generic, biosimilar and value added medicines Medicines for Europe Mon, 11/26/2018 Health & Consumers
HERA must address outstanding weaknesses in EU pharma framework to be successful Medicines for Europe Thu, 09/16/2021 Health & Consumers
IGBA congratulates the Australian Government for maintaining their Biologics Naming Convention and for strengthening pharmacovigilance Medicines for Europe Mon, 01/29/2018 Health & Consumers
IGBA launches a Biosimilar Medicines Information Campaign Medicines for Europe Thu, 02/01/2018 Health & Consumers
Immediately calls on new President of EU Commission to prioritise Healthcare Medicines for Europe Wed, 09/25/2019 Health & Consumers, InfoSociety
IQVIA Institute Scorecards show biosimilar medicines offer win for patients, policymakers and healthcare systems across Europe Medicines for Europe Tue, 06/30/2020 Health & Consumers
Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health Medicines for Europe Fri, 06/16/2017 Health & Consumers
Market reforms needed to secure essential antibiotics against AMR, report says Medicines for Europe Thu, 02/16/2023 Health & Consumers
Maximising the impact of Biosimilar Medicines requires strategic action in Europe Medicines for Europe Thu, 12/05/2024 Health & Consumers
Medicines for Europe announces new President, launches Access to Medicines campaign Medicines for Europe Tue, 10/10/2017 Health & Consumers
Medicines for Europe calls for greater cooperation on value added medicines to improve patient-centric innovation Medicines for Europe Wed, 11/22/2017 Health & Consumers
Medicines for Europe can contribute much more to improve healthcare sustainability than described in the OECD “Health at a Glance 2016” report Medicines for Europe Thu, 11/24/2016 Health & Consumers
Medicines for Europe joins the Antimicrobial (AMR) One Health Network Medicines for Europe Tue, 05/09/2023 Health & Consumers
Medicines for Europe members publish disclosure of Transfers of Value to the healthcare community Medicines for Europe Fri, 06/22/2018 Health & Consumers
Medicines for Europe statement on COVID-19 (‘coronavirus’) Medicines for Europe Fri, 03/13/2020 Health & Consumers
Medicines for Europe to join the ISPOR Issue Panel on value added medicines Medicines for Europe Thu, 10/05/2017 Health & Consumers
Medicines for Europe warns strongly against energy rationing for medicines production Medicines for Europe Wed, 07/20/2022 Health & Consumers
Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines. Medicines for Europe Fri, 11/30/2018 Health & Consumers
Medicines for Europe, APOGEN and Fresenius Kabi hold Open Industry Day in Portugal Medicines for Europe Thu, 11/14/2019 Health & Consumers
New report assesses progress on biosimilar medicine policies across Europe Medicines for Europe Tue, 03/30/2021 Health & Consumers

Pages

Jobs

FEFANA asbl
Regulatory Director
Confederation of the European Bicycle Industry
Communications and Events Internship
Hanns-Seidel-Stiftung
Praktikant (m/w/d)
Group of the European People's Party (EPP Group)
Clerical Officer